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Abstract
With more than 150,000 species, parasitoids are a large group of hymenopteran insects that inject venom into and then lay
their eggs in or on other insects, eventually killing the hosts. Their venoms have evolved into different mechanisms for
manipulating host immunity, physiology and behavior in such a way that enhance development of the parasitoid young.
The venom from the ectoparasitoid Nasonia vitripennis inhibits the immune system in its host organism in order to protect
their offspring from elimination. Since the major innate immune pathways in insects, the Toll and Imd pathways, are
homologous to the NF-kB pathway in mammals, we were interested in whether a similar immune suppression seen in
insects could be elicited in a mammalian cell system. A well characterized NF-kB reporter gene assay in fibrosarcoma cells
showed a dose-dependent inhibition of NF-kB signaling caused by the venom. In line with this NF-kB inhibitory action, N.
vitripennis venom dampened the expression of IL-6, a prototypical proinflammatory cytokine, from LPS-treated
macrophages. The venom also inhibited the expression of two NF-kB target genes, IkBa and A20, that act in a negative
feedback loop to prevent excessive NF-kB activity. Surprisingly, we did not detect any effect of the venom on the early
events in the canonical NF-kB activation pathway, leading to NF-kB nuclear translocation, which was unaltered in venom-
treated cells. The MAP kinases ERK, p38 and JNK are other crucial regulators of immune responses. We observed that venom
treatment did not affect p38 and ERK activation, but induced a prolonged JNK activation. In summary, our data indicate that
venom from N. vitripennis inhibits NF-kB signaling in mammalian cells. We identify venom-induced up regulation of the
glucocorticoid receptor-regulated GILZ as a most likely molecular mediator for this inhibition.
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Introduction
Animal venoms have long been known for their inflammatory
effects, for instance stings from honeybees, snakes and scorpions
can induce ongoing pain and even hyperalgesia [1–3]. But the last
few decades, there has been growing interest in the anti-
inflammatory effects of these venoms. Since Billingham and
colleagues have discovered the anti-inflammatory effects of
honeybee venom, it has been used for the treatment of various
inflammatory diseases in the oriental medicine [4]. With the aim
of finding treatments for several chronic inflammatory diseases (as
rheumatoid arthritis and atherosclerosis) and cancer, venom
components in diverse animal groups have been screened for
possible anti-inflammatory characteristics [5–7].
In the search for animal venom-derived immune suppressive
agents, the parasitoid-host interaction is a highly intriguing system.
When parasitoid wasps lay their eggs in or on a host organism
(endo- or ecto-parasitoid respectively), they also inject a mixture of
virulence factors that consist of ovarian and venom fluids [8].
These parasitoid fluids comprise of different active substances,
exerting a large range of activities in diversified biological
functions [9]. This complexity could allow for adaptation for
new or widened host ranges and could increase the difficulty for a
resistance to emerge considering that a multimodal tolerance
might be set up by the host to insure its survival. The diverse mode
of action of venom proteins from parasitoid wasps is dependent
largely on their life strategy [8]. In ectoparasitoids, like for instance
N. vitripennis, the host generally undergoes a developmental arrest
and immune suppression in order to present a good environment
for the development of the parasitoid offspring [10,11]. The
precise working mechanism of this immune suppression is not yet
exactly characterized. But the polydnaviruses (PDVs) present in
the venom of several endoparasitoid wasp species interfere with
the Toll signaling pathway, which is crucial for maintaining the
host immune response [12].
Toll/Imd receptors are essential for embryonic development
and immunity of insects [13]. The induction of the Toll/Imd
pathway by Gram-positive bacteria and fungi or Gram-negative
bacteria, respectively, leads to the activation of cellular immunity
as well as the systemic release of certain antimicrobial peptides.
Studies in fruit flies and in mammals have revealed that the
defensive strategies of invertebrates and vertebrates are highly
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conserved at the molecular level [14]. Infectious micro-organisms
trigger activation of Toll/Imd receptors in insects or Toll-like
receptors in mammals, which induces a signaling cascade
culminating in the activation of NF-kB transcription factors
[15]. NF-kB is the generic term for members of a family of
transcription factors, that act as homo- or heterodimers and
regulate transcription of multiple genes involved in immunity and
inflammation. The NF-kB family in insects contains three
members (Dif, Dorsal and Relish) and has expanded in mammals,
which have seven NF-kB family members (p50, p105, p65/RelA,
RelB and c-Rel). Different insults trigger the activation of different
NF-kB dimers, which allows fine-tuning of the immune response
[16]. Importantly, the NF-kB pathway is subject to tight feedback
regulation, which ensures termination of NF-kB responses once
the infectious danger has been eliminated [17]. NF-kB is kept
inactive in resting cells by the inhibitor protein Cactus in insects
and by IkB family members in mammals. When cells sense
infectious danger, kinase cascades are activated that promote
phosphorylation and degradation of the NF-kB inhibitor proteins,
leading to NF-kB release and translocation to the nucleus,
eventually activating the transcription of target genes involved in
inflammation [18,19].
Whole genome microarrays on parasitized Drosophila melanogaster
by Leptopilina species revealed gene activation of Toll/NF-kB and
JAK/STAT pathway components, involved in regulating immune
responses toward microbes and macroparasites. The up-regulation
of genes involved in these particular immune pathways suggests
these hosts are better protected against microorganisms at
parasitoid oviposition [20]. In endoparasitoid venoms, the PDVs
encode proteins with ankyrin repeats that are also found in Cactus,
the inhibitor protein of NF-kB signaling in Drosophila, and in
mammalian IkB family members. These viral ankyrin repeats
(vankyrins) however, lack the amino acid sequences necessary for
their degradation/turnover. Therefore, they act as antagonists of
NF-kB nuclear translocation, hence supporting parasite success.
During the last decade, several PDVs in endoparasitoids have been
found to express IkB-related vankyrin genes that suppress NF-kB
activity during immune responses in parasitized hosts [21–25].
In mammalian organisms, the nuclear factor kappa B (NF-kB)
transcription factors regulate important physiological processes,
including inflammation and immune responses [26]. Maintenance
of appropriate levels of NF-kB activity is a critical factor in
immune system development and normal cell proliferation.
Aberrant activation of the NF-kB pathway is involved in the
pathogenesis of a number of human diseases including those
related to inflammation, enhanced cellular proliferation, viral
infection and genetic diseases [27,28]. Asthma for instance is a
chronic inflammation of the bronchial tubes, of which the
activation of NF-kB is stimulated by agents such as allergens,
ozone and viral infections [29]. NF-kB also participates in many
aspects of oncogenesis, since it can suppress apoptosis and induce
expression of proto-oncogenes. The constitutive NF-kB activity
has been observed in a number of human cancers and the
inhibition of NF-kB abrogates tumor cell proliferation [30].
Regulation and control of NF-kB activation can be a powerful
therapeutic strategy for inhibiting tumor growth and viral
infections and for reducing the tissue damage that follows the
release of inflammatory mediators.
Various stimuli give rise to the phosphorylation and degradation
of the inhibitor of NF-kB (IkB) via the IkB kinase (IKK) complex,
leading to NF-kB release and translocation to the nucleus,
eventually activating the transcription of target genes involved in
inflammation [18]. On the other hand, activation of mitogen-
activated protein kinases (MAPKs), including extracellular
signal-regulated kinase 1/2 (ERK1/2), p38 and c-Jun N-terminal
kinase (JNK), is another major signal transduction pathway
involved in inflammation and is closely linked to the activation
of the NF-kB pathway [31]. It is clear that deregulation of the
transcription factor NF-kB can mediate several inflammatory
diseases. Therefore several proteins tightly control its activation
[32]. Among these proteins are the NF-kB inhibitory proteins,
IkBa and A20, the expression of which leads to a negative-
feedback response that terminates activation of NF-kB [33].
Moreover, the NF-kB inflammatory response is also modulated by
endogenous glucocorticoids (GCs) that are released following a
challenge with various cytokines, with the aim to restore
homeostasis. These GCs are steroid hormones that can diffuse
freely across the plasma membrane and bind to their intracellular
receptor, the glucocorticoid receptor (GR). Because of their strong
anti-inflammatory characteristics, GCs have been used since the
late 1940s to treat inflammatory and autoimmune disease
conditions [34].
Nasonia vitripennis is an ectoparasitoid wasp that prefers Sarcophaga
flesh flies as host organism. Bioassays uncovered that the venom of
this wasp causes developmental arrest, increase of lipid levels,
induction of apoptosis in certain tissues and suppression of the host
immune system [35–38]. In contrast with several endoparasitoid
wasps, N. vitripennis only injects venom and no PDVs into the host
and therefore cannot express IkB-related vankyrin genes. Inter-
estingly, microarray analysis on parasitized S. crassipalpis pupae by
N. vitripennis suggested that the venom also targets the NF-kB and
MAPK pathways in the host in order to regulate the immune
response [39]. Since conserved parallels have been noted between
the inflammatory Toll/Imd pathways of Drosophila, and immune
signaling pathways that activate NF-kB in mammals, we have
investigated whether venom from N. vitripennis modulates NF-kB
activation in mammalian cells.
Using a well characterized NF-kB reporter gene assay in
fibrosarcoma cells [40], we found that N. vitripennis venom, at
subcytotoxic doses, inhibits NF-kB activity. In addition, we found
that N. vitripennis venom, in murine macrophage-like Raw264.7
cells, inhibited LPS-induced expression of the pro-inflammatory
NF-kB target Interleukin-6 (IL-6). Our findings suggest that the
venom-induced up-regulation of GILZ, a GR-regulated gene, is
most likely the molecular mediator for this inhibition. One has to
keep in mind, however, that this venom presents a highly complex
mixture that, besides the 79 proteins identified [41], consists of
organic molecules, amines, salts, minerals and alkaloids [42]. The
unique find that the venom of an ectoparasitic wasp is able to
inhibit one of the most important immune pathways in mammals,
focused our research activities in unraveling the effect of the
venom on this pathway in depth. This innovative study therefore,
explored not only the effect of N. vitripennis venom on the
canonical NF-kB pathway, but also the effect on the MAPK
signaling pathways and negative regulatory mechanisms of NF-kB
activation.
Results
1. Effect of venom on NF-kB signaling
a. Venom inhibits NF-kB activation in TNF-stimulated
L929sA fibrosarcoma cells. To assess the effects of N.
vitripennis venom on NF-kB activity, we used a well characterized
NF-kB reporter gene assay [40]. Briefly, the system makes use of
L929sA cells stably transfected with a recombinant promoter with
an NF-kB-responsive element derived from the IL-6 gene
promoter (p(IL6kB)350hu.IL6P-luc+), and a constitutively ex-
pressed reporter gene construct (pPGKbGeobpA), expressing
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b-galactosidase [43]. L929sA cells respond to TNF, followed by an
induction of the NF-kB-reporter gene. Only subcytotoxic concen-
trations of venom were used on the cells (see figure S1 for MTT
cell viability assay). As shown in figure 1, enhanced luciferase
expression levels were measured in response to TNF, whereas
pretreatment with venom was found to potently inhibit reporter
gene expression in a dose-dependent manner (see figure S2 for the
separate luciferase and b–galactosidase read-outs of the NF-kB-
reporter assay). Similar assays were performed on L929sA cells
stably transfected with a recombinant promoter with either the
CRE (cyclic AMP response element) responsive element or the
AP-1 responsive element, which confirmed the specificity of the
venom towards NF-kB (see figure S3).
b. Venom inhibits IL-6 mRNA and protein expression in
LPS-stimulated Raw264.7 macrophages. Interleukin (IL)-6
is a pleiotropic cytokine involved in acute phase and immune
reactions and inflammatory responses, the expression of which in
response to inflammatory stimuli, strongly depends on NF-kB
[44]. Macrophages are key players in the inflammatory response,
and they secrete high levels of IL-6 upon ligation of Toll-like
receptors (TLRs) by pathogen-associated molecular patterns
(PAMPs). We therefore explored the effect of N. vitripennis venom
on TLR4-dependent, LPS-induced IL-6 production in Raw264.7
mouse macrophages. As shown in figure 2A, the elevated levels of
IL-6 protein detected after 6 hours LPS treatment were strongly
repressed in the presence of the venom in a concentration-
dependent manner. Nasonia vitripennis venom pretreatment also
inhibited LPS-induced IL-6 mRNA levels, yet this effect was less
prominent and required ten-fold higher doses of venom (figure 2B).
c. Venom does not interfere with canonical NF-kB
signaling in the cytoplasm. One of the major mechanisms
involved in the transcriptional activation of NF-kB is the activation
of the IKK kinase complex and the concomitant phosphorylation
and degradation of the IkBa protein, which allows the release of
free NF-kB and its subsequent translocation to the nucleus.
Furthermore, post-translational modifications of p65 have been
demonstrated to be critical for p65-driven gene expression of
many target genes [45]. The IKK complex is known to
phosphorylate p65 at serine 536 [46], in this way regulating p65
nuclear localization. We assessed whether N. vitripennis venom
affects these early LPS-induced events in Raw264.7 cells (figure 3).
We found that LPS promoted phosphorylation of IKK in its
activation loop that was apparent after 5 minutes and lasted up to
15 minutes of LPS treatment. Venom pretreatment did not affect
IKK phosphorylation. Next, it was investigated whether the
venom alters LPS-induced phosphorylation of p65. As the Western
blot analysis in figure 3 shows, p65 phosphorylation in Raw264.7
cells is highly increased after 15 minutes LPS induction. However,
no difference in LPS-induced p65 phosphorylation was apparent
after venom co-treatment (figure S4).
d. Venom does not interfere with nuclear translocation of
the p65 subunit. LPS induction in Raw264.7 macrophage cells
leads to canonical NF-kB activation, that is followed by nuclear
translocation of the NF-kB p65 subunit prior to NF-kB/DNA
binding. Therefore, the level of p65 was measured in nuclear
extracts of Raw264.7 cells either untreated or venom-treated for
10, 30 or 60 minutes LPS induction. Antibody against Poly ADP-
Ribose polymerase (PARP) was used as a loading control for the
nuclear fractions. When analyzed by Western blotting, LPS-
induced p65 nuclear translocation was not affected by N. vitripennis
venom (figure 4A). These results were confirmed in figure 4B by
immunofluorescence staining to visualize the trafficking of the p65
subunit. LPS induction after 30 and 60 minutes caused an
accumulation of green fluorescent signal in the nucleus, conform
the translocation of p65 from the cytoplasm to the nucleus. Co-
incubation of these cells with venom, however, did not alter this
translocation.
e. Venom does not interfere with NF-kB transactivation
independent from the promoter context. Since no influence
of N. vitripennis venom was apparent on the subcellular localization
of p65 NF-kB following inflammatory stimuli, the next step was to
investigate whether the observed inhibition of NF-kB activity
(figure 1) could be explained by a nuclear phenomenon. To
approach this question, it was investigated whether N. vitripennis
venom could interfere with NF-kB transactivation, independent
from the promoter context. Therefore, its effect on the transcrip-
tional activation of a Gal4-p65-dependent reporter gene, transac-
tivated by the p65 chimera, was analyzed. This Gal4-p65 fusion
protein, composed of the DNA-binding domain of the yeast
nuclear protein Gal4 and the transactivation domain of the NF-kB
subunit p65, stimulates p(Gal)2-50hu.IL6P-luc+, a luciferase
reporter gene, preceded by two Gal4-binding DNA sequence
elements and the minimal IL-6 promoter. In this particular
nuclear setup, no direct influence of other responsive element-
bound transcription factors, which are normally present in the IL-
6 promoter context, or interference of cytoplasmic events need to
be taken into account. When the glucocorticoid receptor (GR), a
ligand-activated transcription factor present in the cytoplasm,
binds to its agonist, e.g. the synthetic glucocorticoid dexametha-
sone (DEX), the receptor translocates to the nucleus and interferes
with the transactivating function of NF-kB, in a process called
transrepression. Cells were incubated with DEX as a positive
control for transrepression of the NF-kB pathway.
In these experiments, HEK293T cells that are devoid of GR,
were transiently transfected with the expression constructs, and
treated with venom, DEX or were left untreated. Finally, GAL4-
p65 driven expression of luciferase was quantified based on the
measurement of its activity. Whereas Gal4 protein on its own
cannot activate the reporter, overexpression of the nuclear fusion
protein Gal4-p65 clearly activated reporter gene expression, as
Figure 1. Venom from N. vitripennis inhibits TNF-induced
expression of a NF-kB-dependent reporter gene. L929sA cells
stably transfected with a NF-kB-dependent reporter gene were
pretreated with indicated concentrations of venom for 15 minutes
followed by stimulation for 6 hours with TNF (2000 IU/ml). Luciferase
activity was normalized for b-galactosidase expression. The data are
expressed as the mean 6SDs of three biological replicates. Normality
was confirmed by a Shapiro-Wilk test (W=0.9689). * p,0.05, ** p,0.01
versus TNF alone, ANOVA with Bonferroni posthoc test.
doi:10.1371/journal.pone.0096825.g001
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expected (figure 5). After adding DEX to the cells, the level of
transactivation by the nuclear fusion protein Gal4-p65 could be
specifically repressed, when sufficient exogenous GR was present.
However, repression of Gal4-p65-induced transcriptional activa-
tion could not be achieved by the N. vitripennis venom, indicating
that compounds in the venom do not interfere with the
transactivation potential of the p65 subunit in the nucleus or that
they act on specific components of the transcriptional machinery
that is not involved in this Gal4 assay.
2. Effect of venom on MAPK activation pathways: venom
causes prolonged JNK-activation
It is well established that the phosphorylation and, in turn,
activation of MAPKs, i.e. p38, ERK1/2 and JNK, are crucial
for LPS-induced AP-1 and NF-kB activation and subsequent
Figure 2. Effect of N. vitripennis venom on IL-6 production in LPS-stimulated Raw264.7 cells. (A) Cells were stimulated with LPS (1 mg/ml)
for 6 hours, alone or after 15 minutes pre-incubation with various concentrations of venom. IL-6 produced and released into the culture medium was
assayed by ELISA. (B) Cells were stimulated with LPS (1 mg/ml) alone or with indicated amount of venom for 6 hours. Total RNA was isolated and
mRNA expression level of IL-6 was determined by qRT-PCR. hPRT1 and cyclophilin were used to normalize the data. The data are expressed as the
mean 6S.D. of three biological replicates. Normality was confirmed by a Shapiro-Wilk test (W= 0.7617 for A; W=0.8673 for B). * p,0.05, ** p,0.01,
*** p,0.001, **** p,0.0001 versus LPS alone, ANOVA with Bonferroni posthoc test.
doi:10.1371/journal.pone.0096825.g002
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up-regulation of pro-inflammatory mediators in macrophages
[47]. p38 MAP kinase and/or ERK are required for NF-kB
activation in response to LPS and JNK is essential for activation
of transcription factor AP-1 [48–50]. To investigate whether
regulation of the activation of these MAPKs is involved in the
molecular mechanism of action by N. vitripennis venom, phosphor-
ylation of these MAPKs was further examined. Hereto, Raw264.7
cells were pretreated with venom followed by addition of LPS for
different time points. Whole-cell lysates were prepared and the
total expression of these different MAP kinases as well as levels
of phosphorylated MAPKs were determined by Western blot
analysis. The results showed LPS stimulation activates MAPKs in
a time-dependent manner. Pretreatment with venom had no effect
on the LPS-induced phosphorylation of ERK1/2 and p38 (figure 6
and figure S5). However, after 60 minutes LPS induction,
prolonged JNK activation could be observed when N. vitripennis
venom was added to the cells.
3. Effect of venom on NF-kB regulated secondary anti-
inflammatory processes
Next to the well-studied direct regulation of NF-kB signaling,
the regulatory networks that control the NF-kB response are
extensive. The best studied and well accepted mechanism for
termination of the NF-kB response involves the resynthesis of
IkBa proteins induced by activated NF-kB [51]. Newly synthe-
sized IkBa can enter the nucleus, remove NF-kB from the DNA,
and relocalize it to the cytosol [52]. Another important negative
regulator of the NF-kB response is A20, which is up-regulated
following NF-kB activation. Subsequently, A20 down regulates
NF-kB through its dual function as a deubiquitinase and ubiquitin
ligase [53]. Furthermore, glucocorticoids (GCs) are also negative
regulators of NF-kB activation and are widely used as anti-
inflammatory agents [54]. GCs diffuse through the cell membrane
and bind to their inactive cytosolic receptors (GRs), which then
undergo conformational modifications that allow for their nuclear
translocation. In the nucleus, activated GRs modulate transcrip-
tional events by directly associating with DNA elements. In
addition, activated GRs also act by antagonizing the activity of
transcription factors, in particular NF-kB, by direct and indirect
mechanisms [55]. For these reasons, we were interested whether
the venom from N. vitripennis causes any differences in these
secondary regulatory mechanisms of the NF-kB response. We first
tackled this question by looking at the mRNA expression of two
immediate-early genes, IkBa and A20 (figure 7A), and of three
GR-regulated genes, glucocorticoid inducible leucine zipper
(GILZ), mitogen-activated protein kinase (MAPK) phosphatase-1
(MKP1), and FK506 binding protein 51 (FKBP5) (figure 7B). To
study the IkBa and A20 mRNA expression, Raw264.7 cells were
either pretreated with venom or with insect saline buffer (ISB) as a
control and subsequently stimulated with LPS for 30 minutes,
Figure 3. Effect of venom on cytosolic protein activity. Raw264.7
cells were left untreated or were pretreated with 5 mg/ml venom for 15
minutes and then stimulated with 1 mg/ml LPS for the indicated times.
Total cell extracts were assayed by Western blot analysis using
antibodies against indicated proteins. The unphosphorylated protein
and Tubulin-a were used as loading controls. A representative result
from three separate experiments is shown.
doi:10.1371/journal.pone.0096825.g003
Figure 4. Effect of venom on nuclear translocation of p65. A. Western blot analysis of nuclear extracts from Raw264.7. After pre-incubation
with N. vitripennis venom (5 mg/ml) for 15 minutes, cells were induced for the indicated times with LPS (1 mg/ml). Subsequently, nuclear extracts were
subjected to Western blot analysis to determine p65 levels. Separation of nuclear and cytoplasmic fractions was verified using PARP as control for the
nuclear fractions. B. After 15 minutes pre-incubation with N. vitripennis venom, cells were induced for the indicated times with LPS (1 mg/ml).
Immunofluorescence staining was performed to visualize the trafficking of the p65 subunit. Representative results from three separate experiments
are shown.
doi:10.1371/journal.pone.0096825.g004
Anti-Inflammation by Venom from Nasonia vitripennis
PLOS ONE | www.plosone.org 5 May 2014 | Volume 9 | Issue 5 | e96825
1 hour, 3 or 6 hours. Then, RNA was isolated from the cells,
reverse-transcribed and analyzed by real-time PCR. As shown in
figure 7A, mRNA expression of IkBa and A20 is up-regulated
after 1 hour of LPS induction and remains elevated for 6 hours
after LPS induction. When venom is applied to the cells, both
IkBa and A20 expression are significantly suppressed after 1 hour
and after 6 hours LPS induction. Next, the transcriptional
response on several GR-regulated genes was investigated. The
synthetic ligand of GR, dexamethasone (DEX) was used as a
positive control and the GR antagonist RU38486 was used to
monitor whether the ligand-binding domain of GR was affected by
the venom. Raw264.7 cells were pre-incubated with RU38486 for
1 hour when indicated and then stimulated with DEX or with
venom for 6 hours. As the results in figure 7B show, the
transactivation by DEX causes an increase in all three tested
genes, while the prior addition of the antagonist resulted in a
decrease of their expression, as expected. Interestingly, when
N. vitripennis venom was added to the cells, an increase in GILZ
expression could also be seen, halfmaximal to the increase caused
by DEX. Notably, venom-induced MKP1 expression was even
higher than the response to DEX. However, no effect of venom
was apparent on FKBP5 expression. RU38486 addition prior to
venom did not affect gene expression of these three GC indicator
genes.
Since venom suppressed IkBa and A20 mRNA expression, we
were interested whether this was concomitant with a suppression
at the protein level. Therefore, Raw264.7 cells either or not
pretreated with N. vitripennis venom, were treated with LPS for 30
minutes, 1 hour, 2, 3 or 6 hours (figure 8 and figure S6). Western
blot analysis showed that IkBa is almost completely degraded after
30 minutes and its resynthesis was detectable after 2 hours of LPS
induction. When venom was applied on the cells, the resynthesis of
IkBa remains suppressed even after 6 hours of LPS induction.
This probably means that the lowered amount of IkBa mRNA
caused by the venom (figure 7A) resulted in less translated IkBa
Figure 6. Effect of N. vitripennis venom on LPS-induced
phosphorylation of MAPKs. Raw264.7 cells were either left
untreated or treated with venom (5 mg/ml) for 15 minutes followed
by stimulation with 1 mg/ml LPS for the indicated times. Total cell
extracts were assayed by Western blot analysis using the indicated
antibodies. Tubulin-a and the respective unphosphorylated proteins
were used as loading controls. A representative result from three
separate experiments is shown.
doi:10.1371/journal.pone.0096825.g006
Figure 5. Effect of N. vitripennis venom on the Gal4-p65-mediated expression of a reporter gene in a Gal4 one-hybrid setup. HEK293T
cells were transiently transfected by the PEI method with 100 ng of p(Gal)2-50.huIL6P-luc+ and with various expression plasmids, the total amount of
DNA being fixed at 250 ng, i.e., pGal4 (10 ng) or pGal4-p65 (10 ng) whether or not with pGR (25 ng). 1026 M DEX or 5 mg/ml of venom was added
24 hours before analysis. Lysates were made and the relative luciferase activity was determined by using b-gal values as a basis for normalization. The
data are expressed as the mean 6S.D. of three biological replicates.
doi:10.1371/journal.pone.0096825.g005
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protein. When looking at the presence of A20, an elevation at the
protein level was noticed after 2 and 3 hours LPS induction.
Venom caused a slight elevation of A20 after 2 hours of LPS
induction, but a significant suppression could be noted when LPS
was applied to the cells for 3 hours. This is probably the result of
the suppressed A20 mRNA expression (figure 7A).
Discussion
Studies on the immune suppressive effect of N. vitripennis venom
have always been directed on hemocytes of their hosts [56,57] or
cultured insect cells [37] [56] [58–60]. While investigating the
possible function of parasitoid venom on mammalian cells may
seem unlogic at first, the plethora of available research tools in
these cell lines, that highly exceeds what is available in insect cell
lines, convinced us to start working on mammalian cell lines.
Secondly, NF-kB transcription factors, the MAPK signal trans-
Figure 7. Effect of N. vitripennis venom on the mRNA expression of secondary anti-inflammatory processes. A. Raw264.7 cells were
stimulated with LPS (1 m/ml) alone or with 5 mg/ml venom for 30 minutes, 1 hour, 3 or 6 hours. Total RNA was isolated and the mRNA expression of
IkBa and A20 was determined by qRT-PCR. hPRT1 and cyclophilin were used to normalize the data. The data are expressed as the mean 6S.D. of
three biological replicates. Normality was confirmed by a Shapiro-Wilk test (W= 0.9131 for IkBa; W= 0.8630 for A20). * p,0.05, ** p,0.01, *** p,
0.001 for the LPS group compared with the respective LPS and venom group, ANOVA with Bonferroni posthoc test. B. Raw264.7 cells were pre-
incubated with RU38486 for 1 hour when indicated and then stimulated with 10-6 M DEX or with 5 mg/ml venom for 6 hours. Total RNA was isolated
and the mRNA expression of GILZ, MKP1 and FKBP5 was determined by qRT-PCR. hPRT1 and cyclophilin were used to normalize the data. The data
are expressed as the mean 6S.D. of three biological replicates. Normality was confirmed by a Shapiro-Wilk test (W= 0.8952 for GILZ; W= 0.8834 for
MKP1; W= 0.8424 for FKBP5). *** p,0.001, **** p,0.0001 for the DEX or venom group compared with the respective vehicle group and for the DEX +
RU38486 or venom + RU38486 group compared with the respective RU38486 group, ANOVA with Bonferroni posthoc test.
doi:10.1371/journal.pone.0096825.g007
Figure 8. Effect of venom on IkBa and A20 protein levels.
Raw264.7 cells were left untreated or were pretreated with 5 mg/ml
venom for 15 minutes and then stimulated with 1 mg/ml LPS for the
indicated times. Total cell extracts were assayed by Western blot
analysis using antibodies against indicated proteins. Tubulin-a was used
as a loading control. A representative result from three separate
experiments is shown.
doi:10.1371/journal.pone.0096825.g008
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duction pathways and the glucocorticoid receptor signaling
pathway that were studied, are evolutionary conserved in
metazoan animals [61–65]. Finally, there is an enormous request
for anti-inflammatory compounds in medicine that represents the
high amount of future applications available [66]. Since so many
diseases are driven by chronic inflammatory responses, finding
good drugs to control this excessive immune response has been the
focus of much research. The last few decades, venoms have also
been added to the growing list of anti-inflammatory drugs [67].
The extraordinary finding that the venom of a parasitoid wasp
is able to suppress the major mammalian immune pathway,
intrigued us to fully disentangle this interaction. Respectively, we
are the first to investigate the inhibitory effect of N. vitripennis
venom on the NF-kB pathway in mammalian cells and to suggest
its mode of action.
Previous experiments on natural host organisms have shown
that maternally derived venom from N. vitripennis disrupts host
immune responses almost immediately following oviposition [38].
Microarray analysis on parasitized S. crassipalpis pupae by
N. vitripennis already suggested NF-kB and MAPK pathways in
the host as potential candidates for the regulation of the immune
response to envenomation [39]. The current study was conducted
to investigate the potential anti-inflammatory and anti-NF-kB
responses of N. vitripennis venom on mammalian cells. A proposed
model of the interactions between the venom and the NF-kB
pathway is illustrated in figure 9. Since this venom has a high
cytotoxicity to certain insect cell types [68], cell viability was tested
to establish the appropriate concentration ranges of venom for the
analysis of ongoing experiments. When incubation periods of
6 hours were applied, 5 or 10 mg/ml venom appeared to be non-
toxic concentrations and were used in further experiments. Our
Figure 9. Proposed model of venom interference with the NF-kB and glucocorticoid signaling pathways. TNF stimulation leads to
activation of the canonical NF-kB signal transduction pathway marked by IkBa degradation and translocation of the p65-p50 dimer to the nucleus.
Subsequent NF-kB DNA binding enables transcription of different genes, among which the cytokine IL-6. Venom treatment leads to the inhibition of
TNF induced IL-6 gene expression. In addition, TNF activates the MAPKs,JNK, ERK1/2 and p38, and pretreatment with venom results in prolonged JNK
activation. The negative NF-kB regulators A20 and IkBa are indicated and both were suppressed by the venom. Glucocorticoid binding to the
cytosolic Glucocorticoid Receptor (GR) results in the dissociation of chaperoning proteins, followed by GR translocation to the nucleus, where it can
interfere with the activity of NF-kB. Activated GR can also directly bind to the DNA, stimulating transcription of FKBP5, MKP1 and GILZ target genes.
Only the two latter genes are transcriptionally induced by the venom. The red arrows mark the various levels at which venom of N. vitripennis
interferes with the represented cellular signaling pathways.
doi:10.1371/journal.pone.0096825.g009
Anti-Inflammation by Venom from Nasonia vitripennis
PLOS ONE | www.plosone.org 8 May 2014 | Volume 9 | Issue 5 | e96825
initial focus was to see whether N. vitripennis venom could inhibit
the NF-kB immune signaling pathway. This was first studied in
murine fibrosarcoma cells stably transfected with a recombinant
promoter that has an NF-kB-responsive element. Interestingly,
when these cells were incubated with N. vitripennis venom, a clear
dose-related inhibition of relative luciferase activity could be
noted. Venom-mediated suppression of the NF-kB pathway could
be confirmed in Raw264.7 macrophages, since the venom dose-
dependently suppressed IL-6 mRNA and protein expression. This
is a remarkable result, since this is the first report that venom from
an ectoparasitic wasp is able to suppress NF-kB signaling in
mammalian cell lines.
The following study focused on localizing the intrusion step by
venom compounds. In 2006, Gilmore and Herscovitch reported
on the identification of more than 785 inhibitors of NF-kB
signaling [69]. They noted that in most cases, inhibition is based
on a given agent’s ability to block one or more steps of NF-kB
signaling in a tissue culture-based system after stimulation of
resting cells with an NF-kB inducer, most commonly either TNF
of LPS. More than half of those described NF-kB inhibitors block
a signal before the NF-kB dimer is able to bind the DNA in the
nucleus. Nasonia vitripennis venom however, did not cause an effect
on the cytosolic events, nor on the translocation of the NF-kB
dimer to the nucleus for binding to the DNA, nor did it disturb the
transactivation function of p65. These intriguing results forced our
research activities into the direction of other pathways or
regulatory mechanisms that could result into this inhibition of
NF-kB activity.
The phosphorylation and activation of three major MAPKs –
p38, ERK1/2 and JNK – have been shown to initiate
inflammatory gene expression in LPS-induced macrophages.
Therefore, the effect of venom on these pathways was also
investigated. Interestingly, we found that venom prolonged LPS-
induced JNK activation in Raw264.7 macrophages. Genotoxic
stresses, e.g. UV or c-irradiation, and TNF-induced reactive
oxygen species (ROS) accumulation induce long-lasting or
prolonged MAPK activation, which in turn contributes to cell
death [70]. NF-kB on the other hand, can protect cells against
TNF cytotoxicity by inhibiting the sustained phase of TNF-
induced JNK activation [71]. Prolonged JNK activation as a result
of venom induction could be the result of NF-kB inhibition and
eventually even lead to cell death. Indeed, N. vitripennis venom
induces apoptosis of insect cells [72], while in murine macrophag-
es, only high doses and long induction times were cytotoxic to the
cells.
Since aberrant NF-kB activity can directly lead to uncontrolled
tissue damage and deleterious disease [73,74], the NF-kB driven
inflammatory responses need to be down-regulated and properly
terminated. Therefore, many distinct negative regulatory feedback
mechanisms have evolved that operate at different molecular levels
in the NF-kB signaling pathway [17]. For instance, several
proteins among which IkBa and A20, are NF-kB target genes,
constituting a negative-feedback response. Nasonia vitripennis venom
was, by causing suppression of inhibitors of NF-kB signaling,
indirectly found to give rise to an elimination of this negative-
feedback response. The abrogation of this negative regulation can
therefore be seen as the normal consequence of the venom-
induced suppression of the NF-kB activity. Another regulation of
the NF-kB activation is realized by glucocorticoids [75]. Today,
nothing is known about possible steroids or corticoid-like
substances in N. vitripennis venom. However, besides peptides and
proteins, venoms are known to contain organic molecules, amines,
alkaloids, salts and minerals [76] and recently, the venom from the
toad Bufo bufo gargarizans was found to contain steroids that
displayed potent inhibitory activities against cancer cells [77].
When we looked at genes that are regulated by GR, N. vitripennis
venom induction caused an up-regulation of GILZ and MKP1.
Intriguingly, GILZ and MKP1 are known to inhibit NF-kB
signaling; GILZ through the interaction with p65 [78], and MKP1
via dephosphorylation and inactivation of members of MAPK
family, preferably JNK and p38 MAPK [79]. Studies in T
lymphocytes demonstrated that GILZ reduced NF-kB transcrip-
tional activity [80]. Subsequent in vivo studies showed that
administration of a GILZ peptide inhibits disease development in
the experimental autoimmune encephalomyelitis model of multi-
ple sclerosis, in part via effects on T cell activation [81]. Together,
these findings demonstrate a suppressive role of GILZ in the
regulation of immune cell activation. We speculate GILZ up-
regulation as the most likely candidate for the venom-induced
effect, but the precise mode of action still needs to be elucidated.
We can conclude that in analogy with inhibition of immune
responses in the natural insect host, also in mammalian cells anti-
inflammatory responses of the venom can be observed. However,
an interesting difference concerning MAPK pathways was
observed. While the microarray study on the insect host showed
significant down-regulation of a MAPK gene and up-regulation of
a MAPK-phosphatase, an increase in activation of the JNK
pathway was seen in the mammalian system. Apparently, the
venom has a different mode of action in insects than in
mammalian cells, which seems interesting to investigate more into
detail.
In view of the complexity of the NF-kB pathway, the
identification of specific inhibitors with acceptable side-effects
has been challenging, and new molecules are still actively sought
after. Perhaps, venom from the ectoparasitoid wasp N. vitripennis
can meet with these conditions by looking at the results presented
here, but for sure, future experiments need to explore this further.
Materials and Methods
1. Isolation of crude wasp venom
Nasonia vitripennis wasps were reared on pupae of the flesh fly,
Sarcophaga crassipalpis, and maintained at 25uC with a daily 15:9
light: dark cycle. Female wasps were allowed to host feed on flesh
fly pupae for 24 hours. Venom gland reservoirs were dissected into
insect saline buffer (ISB) [150 mM NaCl, 10 mM KCl, 4 mM
CaCl2, 2 mM MgCl2, 10 mM Hepes] [82] and centrifuged at
12,0006g for 10 minutes at 4uC. The supernatant containing the
venom was transferred to a clean microcentrifuge tube and stored
frozen at 270uC. Total protein in crude venom was determined
colorimetrically at 595 nm using a Coomassie Protein Assay
Reagent (no 23200, Thermo Scientific).
2. Chemicals
The origin and activity of TNF, as well as the preparation of
luciferase (luc) reagent, were described previously [43]. Dexa-
methasone (DEX), LPS from Escherichia coli, mouse anti-tubulin-a
and the specific GR antagonist RU38486 were purchased from
Sigma Chemical Co. (St. Louis, MO). Antibodies to rabbit IkBa
(C-21), mouse A20 (A-12), rabbit PARP-1/2 (H-250 and rabbit
NF-kB p65 (C-20) were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Antibodies to rabbit phospho-IKKa
(ser180)/(ser181)b, rabbit phospho-NF-kB p65(ser536), rabbit
phospho-ERK MAPK and rabbit phospho-p38 MAPK were
purchased from Cell Signaling Technology (Danvers, MA, USA).
Corresponding fluorescent-coupled secondary antibodies were
purchased from Rockland, Gilbertsville, PA.
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3. Cell culture
Raw264.7 cells, a mouse macrophage-like cell line, were
maintained in RPMI 1640 medium, murine fibrosarcoma
L929sA cells and human embryonic kidney (HEK) 293T cells
were maintained in DMEM at 37uC in 5% CO2 humidified air.
Both media were supplemented with 10% fetal bovine serum, 100
units/ml penicillin and 0.1 mg/ml streptomycin. Twenty-four
hours before induction, cells were seeded in multiwell dishes such
that they were confluent at the time of the experiment.
4. Plasmids and transfection procedure
pGal4, pGal4-p65 and p(Gal)2-50hu.IL6P-luc+ were previously
described [83]. pPGKbgeobpA was a gift from P. Soriano (Fred
Hutchinson Cancer Research Center, Seattle). p(IL6kB)350-
hu.IL6P-luc+ [40] and p(GRE)2-50-luc [84] were described
previously. Transient transfections were performed using poly-
ethylenimine (PEI) [85]. Stable transfection was performed by the
calcium phosphate precipitation procedure according to standard
protocols [43].
5. Reporter gene analysis
Luciferase (luc) and galactosidase reporter assays were carried
out according to the manufacturer’s instructions (Promega) and
have been described previously [43]. Luc activity, expressed
in arbitrary light units, was corrected for differences in protein
concentration and transfection efficiency in the sample by
normalization to constitutive b-gal levels. B-gal levels were
quantified with a chemiluminescent reporter assay Galacto-Light
kit (TROPIX).
6. Enzyme-linked immunosorbent assay of IL-6
Murine IL-6 ELISA was performed using the Mouse IL-6
CytoSet from Invitrogen.
7. Western blot analysis
After inductions (indicated in the figure’s legends) or solvent
controls where appropriate, cells were washed with ice-cold
phosphate-buffered saline (PBS), harvested with a rubber police-
man and collected in 1 ml of PBS by centrifugation for 10 minutes
at 500 g (4uC). Preparation of cytoplasmic or nuclear cell extracts
have been described previously [40]. If total cell lysates were used,
cells were lysed in SDS sample buffer [62.5 mM Tris-HCl,
pH 7.5, 2% (w/v) SDS, 10% glycerol, 50 mM dithiothreitol
(DTT), and 0.01% (w/v) bromophenol blue]. To shear DNA and
reduce sample viscosity, lysates were sonicated for 1 minute in a
water bath sonicator and then heated to 95uC for 5 minutes after
which they were immediately cooled in ice and microcentrifuged
for 5 minutes. The lysates were separated by 10% SDS-PAGE and
electrotransferred onto a nitrocellulose membrane. Blots were
probed using the appropriate antibodies (1:1,000), and their
corresponding immunoreactive protein (1:10,000) was detected on
an Odyssey imaging system (LI-COR Biosciences, Lincoln, USA).
8. RNA analysis
RNA was isolated by using TRIzol Reagent (Invitrogen) as
described previously [84]. Total RNA was reverse-transcribed into
cDNA using the Revert Aid H Minus First Strand cDNA
Synthesis Kit (Fermentas) following the manufacturer’s instruc-
tions. The expression of the genes was determined by qRT-PCR
in a CFX96 Real-Time PCR Detection System (BioRad,
Hercules, CA, USA) using the SYBR Green mastermix (Invitro-
gen). The following mouse-specific primers were used:
IL-6 forward 59-GAGGATACCACTCCCAACAGACC-39;
IL-6 reverse 59-AAGTGCATCATCGTTGTTCATACA-39;
IkBa forward 59-TGAAGGACGAGGAGTACGAGC-39;
IkBa reverse 59-TTCGTGGATGATTGCCAAGTG-39;
A20 forward 59-CCTTGCTTTGAGTCAGGCTGT-39;
A20 reverse 59-TAAGGAGAAGCACGAAACATCGA-39;
FKBP5 forward 59-TGAGGGCACCAGTAACAATGG-39;
FKBP5 reverse 59-CAACATCCCTTTGTAGTGGACAT-39;
MKP1 forward 59-GAGCTGTGCAGCAAACAGTC-39;
MKP1 reverse 59-CTTCCGAGAAGCGTGATAGG-39;
GILZ forward 59-CCAGTGTGCTCCAGAAAGTGTAAG-
39;
GILZ reverse 59-AGAAGGCTCATTTGGCTCAATCTC-39.
An average of the following household genes was used for
normalization:
cyclophilin forward 59-GCATACGGGTCCTGGCATCTT-
GTCC-39;
cyclophilin reverse 59-ATGGTGATCTTCTTGCTGGTC-
CTTGC-39;
hPRT forward 59-CCTAAGATGAGCGCAAGTTGAA-39;
hPRT reverse 59-CCACAGGACTAGAACACCTGCTAA-39.
The thermal cycling conditions were as follows: 5 minutes at
50uC, 2 minutes at 95uC and then 40 cycles of 20 seconds at 95uC
and 40 seconds at 60uC. Melting curve analysis was used to
determine primer specificity.
9. Immunofluorescence staining
Cells were seeded on coverslips and grown for 24 hours.
Fixation, permeabilization, and staining were performed as
described previously [84]. Presence of p65 was visualized with a
1:200 dilution of anti-p65 antibody, followed by probing with a
1:800 dilution of Alexa Fluor 488–conjugated goat anti-rabbit
IgG. Staining with 4,6-diamidino-2-phenylindole (DAPI) was used
for visualization of the cell nuclei. A Zeiss Axiovert 200M
microscope was used for visualization of the images, and data were
analyzed using Carl Zeiss Axiovision software (Carl Zeiss
Instruments, Jena, Germany).
10. Statistical analysis
All assays were carried out in triplicate from three biological
repeats and results were expressed as the mean 6SDs. Prior to
statistical tests, normality of the data was confirmed by Shapiro-
Wilk tests. With this assumption met, data was evaluated using
analysis of variance, ANOVA followed by Dunn’s or Bonferroni
posthoc test. P-value ,0,05 was considered statistically significant.
All statistical analyses were performed with Prism 5.0 (GraphPad
Software, Inc., La Jolla, CA).
Supporting Information
Figure S1 Effect of N. vitripennis venom on cell viability
in Raw264.7 cells. Viability was measured after 6 and 24 hours
venom incubation in an MTT assay by adding 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) so-
lution (0,5mg/ml) to the cells. This solution was incubated at 37uC
until blue deposits were visible. The formazan crystals were then
solubilized in SDS/HCl solution and incubated for 5 hours
at 37uC. The absorbance was determined colorimetrically at
595 nm. White bars represent 6 hours venom incubation, black
bars represent 24 hours venom incubation. Normality was
confirmed by a Shapiro-Wilk test (W=0.9677). * p-value ,0.05,
ANOVA and Dunn’s test.
(TIF)
Figure S2 Venom from N. vitripennis inhibits TNF-
induced expression of a NF-kB-dependent reporter gene:
Anti-Inflammation by Venom from Nasonia vitripennis
PLOS ONE | www.plosone.org 10 May 2014 | Volume 9 | Issue 5 | e96825
not normalized luciferase and b–galactosidase values.
L929sA cells stably transfected with a NF-kB-dependent reporter
gene were pretreated with indicated concentrations of venom for
15 minutes followed by stimulation for 6 hours with TNF
(2000 IU/ml). (A) Luciferase activity and (B) b-galactosidase
expression. The data are expressed as the mean 6S.D. of three
biological replicates. Normality was confirmed by a Shapiro-Wilk
test (W=0.9337 for A; W=0.9662 for B). * p,0.05, **** p,
0.0001 versus TNF alone, ANOVA with Bonferroni posthoc test.
(TIF)
Figure S3 Venom does not inhibit PMA- or dB-cAMP-
induced expression of neither an AP-1-dependent re-
porter gene, nor a CRE-dependent reporter gene
respectively. On the left, L929sA cells stably transfected with
an AP-1-dependent reporter gene were pretreated with indicated
concentrations of venom for 15 minutes followed by stimulation
for 6 hours with phorbol 13-myristate 12-acetate (PMA) (10 nM).
On the right, L929sA cells stably transfected with a CRE-
dependent reporter gene were pretreated with indicated concen-
trations of venom followed by stimulation for 6 hours with N(6),29-
O-dibutyryladenosine 39:59 cyclic monophosphate (dB-cAMP)
(100 mM). (A) Luciferase activity, (B) b-galactosidase expression
and (C) normalized expression. The data are expressed as the
mean 6S.D. of three biological replicates. Normality was
confirmed by a Shapiro-Wilk test (W=0.8744 and W=0.7985
for A left and right respectively; W=0.9124 and W=0.9521 for B
left and right respectively; W=0.9195 and W=0.8226 for C left
and right respectively). ANOVA with Bonferroni posthoc test.
(TIF)
Figure S4 Histograms of Western blots that show the
effect of venom on cytosolic protein activity. Raw264.7
cells were left untreated or were pretreated with 5 mg/ml venom
for 15 minutes and then stimulated with 1 mg/ml LPS for the
indicated times. Total cell extracts were assayed by Western blot
analysis using antibodies against indicated proteins: (A) P-IKKa/b
normalized with the unphosphorylated IKKb, (B) P-p65 normal-
ized with the unphosphorylated p65. Bands of these proteins were
quantified and data are expressed in histograms as the mean
6S.D. of three biological replicates. Normality was confirmed by a
Shapiro-Wilk test (W=0.7242 for A; W=0.8585 for B). Statistics
were performed by ANOVA with Bonferroni posthoc test.
(TIF)
Figure S5 Histograms of Western blots that show the
effect of venom on phosphorylation of MAPKs. Raw264.7
cells were left untreated or were pretreated with 5 mg/ml venom
for 15 minutes and then stimulated with 1 mg/ml LPS for the
indicated times. Total cell extracts were assayed by Western blot
analysis using antibodies against indicated proteins. (A) P-p38
normalized with p38, (B) P-ERK normalized with ERK, (C) P-
JNK normalized with JNK. Bands of these proteins were
quantified and data are expressed in histograms as the mean 6
S.D. of three biological replicates. Normality was confirmed by
a Shapiro-Wilk test (W=0.7085 for A; W=0.8703 for B;
W=0.9012 for C). * p,0.01 versus TNF alone, ANOVA with
Bonferroni posthoc test.
(TIF)
Figure S6 Histograms of Western blots that show the
effect of venom on IkBa and A20 protein levels. Raw264.7
cells were left untreated or were pretreated with 5 mg/ml venom
for 15 minutes and then stimulated with 1 mg/ml LPS for the
indicated times. Total cell extracts were assayed by Western blot
analysis using antibodies against indicated proteins. (A) IkBa
normalized with Tubulin- a, (B) A20 normalized with Tubulin-a.
Bands of these proteins were quantified and data are expressed in
histograms as the mean 6S.D. of three biological replicates.
Normality was confirmed by a Shapiro-Wilk test (W=0.9253 for
A; W=0.7062 for B). * p,0.01, ** p,0.001 versus TNF alone,
ANOVA with Bonferroni posthoc test.
(TIF)
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